### What is Androgenetic Alopecia? Etiology and Pathogenesis
Androgenetic alopecia (AGA) is the most common type of progressive hair loss, commonly known as “seborrheic alopecia” or “hereditary hair loss.” It affects both men and women, but presents differently: in men, it typically manifests as a receding frontal hairline and thinning of the crown; in women, it often presents as a gradual widening of the part line on the crown, while the frontal hairline is usually preserved. This type of hair loss is not caused by a single factor, but rather by the combined effects of genetics, hormones, and environmental factors.
### Etiology: Genetics as the Foundation, Androgens as the “Catalyst”
Extensive evidence-based medical evidence indicates that androgenetic alopecia has a clear genetic predisposition. If male relatives in the family (such as father, grandfather) experience hair loss at a young age, the risk of developing the condition in offspring is significantly increased. Multiple gene loci have been identified to be associated with AGA, the most common of which is the androgen receptor (AR) gene located on the X chromosome. Since males have only one X chromosome (from the mother), the maternal family history of hair loss may have a greater impact on males; however, other genes on autosomes also participate in regulation, so heredity is not absolutely determined by a single parent.
Androgens play a key role in the pathogenesis of AGA, particularly dihydrotestosterone (DHT). DHT is a more potent androgen converted from testosterone under the catalysis of 5α-reductase. In genetically susceptible individuals, hair follicles in specific areas of the scalp (such as the forehead and crown) are highly sensitive to DHT. This sensitivity arises from abnormal expression levels or activity of androgen receptors in follicle cells. It should be emphasized that testosterone and DHT levels in AGA patients are usually within the normal range; the problem lies in the hair follicles’ overreaction to normal androgen levels, rather than an abnormality in the hormone concentration itself.
### Pathogenesis: The Molecular Process of Follicle “Miniaturization”
The normal hair growth cycle includes anagen (2–7 years), catagen (about 2 weeks), and telogen (about 3–4 months). In androgenetic alopecia, DHT binds to androgen receptors on dermal papilla cells, triggering a series of intracellular signaling pathway changes, leading to gradual miniaturization of hair follicles. Specifically, DHT inhibits dermal papilla cells from secreting hair growth-promoting factors (such as insulin-like growth factor-1, vascular endothelial growth factor, etc.), while upregulating transforming growth factor-β, which inhibits hair growth. This imbalance causes hair follicles to prematurely enter the telogen phase from the anagen phase, shortening the anagen phase and prolonging the telogen phase. Eventually, shed hairs become thinner, shorter, and lighter in color.
With each hair follicle cycle, the miniaturized follicles produce finer vellus hairs (similar to body hair) and eventually completely degenerate; the follicular opening appears closed, but hair follicle stem cells are usually not completely lost. This process begins on the crown and forehead because hair follicles in these areas naturally have higher 5α-reductase activity and androgen receptor density. Hair follicles in the occipital and temporal regions, due to differences in gene expression, are usually insensitive to DHT, which is the principle behind why hair transplant surgery can use these follicles for grafting.
### Uniqueness of Female Androgenetic Alopecia
Female patients often have normal androgen levels, but their hair follicles are still sensitive to androgens. Additionally, after menopause, estrogen levels decline, which may disrupt the hormonal balance, allowing previously suppressed androgen effects to manifest. Female hair loss pattern is mainly diffuse thinning on the crown, with complete baldness being rare. Some women may have coexisting endocrine disorders such as polycystic ovary syndrome (PCOS), and testing is needed to rule out other causes.
### Other Influencing Factors
Although genetics and androgens are the core mechanisms, stress, lack of sleep, malnutrition, or certain medications (such as some antidepressants, oral contraceptives) may exacerbate the hair loss process. These factors can affect systemic hormone levels or local microcirculation, but they are not independent causes. Currently, there is no evidence that “shampoo residue,” “excessive scalp oil,” or “hair mites” directly cause androgenetic alopecia; these are mostly coexisting appearances or folk myths.
### Summary
The fundamental mechanism of androgenetic alopecia can be summarized as: genetic susceptibility + androgens (mainly DHT) → hair follicle miniaturization → progressive hair loss. This is a slow, gradual process that usually begins after puberty and worsens with age. Currently, evidence-based medical treatments include FDA-approved topical minoxidil, oral finasteride (for men only), and low-level laser therapy, among others. It is recommended that individuals troubled by hair loss visit a dermatology department at a regular hospital for a definite diagnosis using methods such as trichoscopy and hormone testing, and avoid using unverified “hair growth products” on their own.
**(For reference only, does not constitute medical advice)**